3 Recruiting Newly Diagnosed Multiple Myeloma Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by State
Browse by Study Phase
Top Interventions for Newly Diagnosed Multiple Myeloma
Top Recruiting Newly Diagnosed Multiple Myeloma Studies
🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic
Study of SubQ Dara With Dose-Attenuated Bortezomib, Lenalidomide, Dexamethasone in Elderly NDMM
📍 Icahn School of Medicine at Mount Sinai — New York, New York
View Study & Checklist ➔ 🟡 Not Yet Recruiting Phase1 / Phase2 💊 Investigational Drug / Biologic
Phase 1b/2: Isatuximab, Iberdomide, Bortezomib, Dexamethasone in Transplant Ineligible/Deferred Newly Diagnosed Myeloma
📍 Beth Israel Deaconess Medical Center (BIDMC) — Boston, Massachusetts
View Study & Checklist ➔ 🟢 Recruiting Phase3 💊 Investigational Drug / Biologic
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
📍 Research Site — Gilbert, Arizona
View Study & Checklist ➔